← Open Payments lookup

ANTHONY LUMBAD: Open Payments

NPI 1679965693 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$219 in 11 payments from 8 companies in 2025. Trend: 2023 $103 · 2024 $103 · 2025 $219

Food & beverage: $219
CompanyPaymentsAmount
Edwards Lifesciences Corporation1$56
ABIOMED2$43
BridgeBio Pharma, Inc.2$33
PFIZER INC.2$29
E.R. Squibb & Sons, L.L.C.1$16
Novo Nordisk Inc1$15
Alnylam Pharmaceuticals Inc.1$14
Novartis Pharmaceuticals Corporation1$14

Products named: SAPIEN 3 Ultra RESILIA, Attruby, ELIQUIS, CAMZYOS, Wegovy, AMVUTTRA, LEQVIO.

Industry payments across OR — which companies pay providers there.